Karl Neumann wrote a guest piece for the Drug & Device Law Blog discussing Ramkelewan v. Globus Medical Inc. No. 5:18-cv-100, 2019 U.S. Dist. LEXIS 229357 (M.D. Fla. Dec. 10, 2019). He explains, in the subsequent lawsuit against the manufacturer, the plaintiff alleged a host of highly speculative manufacturing defect theories. At its core, the complaint stated the plaintiff’s damages were caused by a defectively manufactured device that did not comply with design specifications approved by the FDA.
To read the full article, click here.